Prostate cancer cell lines secrete the ghrelin peptide and exogenous ghrelin treatment stimulates cell proliferation in prostate cancer cell lines and this is mediated through the ERK1/2 MAPK pathway [16,18]. The gene discussed is MAPK3; the disease is prostate carcinoma.